Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte/macrophages via mitogen-activated protein kinase and nuclear factor-κb pathways

International Archives of Allergy and Immunology

Volumn 149, Issue 3, 2009, Pages 275-282

  Hashimoto, Kunio ^a   Ichiyama, Takashi ^a   Hasegawa, Masanari ^a   Hasegawa, Shunji ^a   Matsubara, Tomoyo ^a   Furukawa, Susumu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cysteinyl leukotriene; Mitogen activated protein kinase; Monocyte chemoattractant protein 1; Monocyte macrophages; Nuclear factor B

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CAFFEIC ACID PHENYLETHYL ESTER; CD14 ANTIGEN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDOLEUKOTRIENE; PRANLUKAST; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE D4 RECEPTOR; LEUKOTRIENE RECEPTOR; PROTEIN KINASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; BIOSYNTHESIS; DRUG POTENTIATION; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CHEMOKINE CCL2; HUMANS; LEUKOTRIENE C4; LEUKOTRIENE D4; MACROPHAGES; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; NF-KAPPA B; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RECEPTORS, LEUKOTRIENE; SIGNAL TRANSDUCTION;

EID: 59849121110     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000199724     Document Type: Article

References (39)

1. 4: synthesis and structure-activity relationships. J Med Chem 1988;31:84-91.
2. Diamant Z, Hiltermann JT, van Rensen EL, Callenbach PM, Veselic-Charvat M, van der Veen H, Sont JK, Sterk PJ: The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma. Am J Respir Crit Care Med 1997;155:1247-1253.
3. Henderson WR Jr, Tang LO, Chu SJ, Tsao SM, Chiang GK, Jones F, Jonas M, Pae C, Wang H, Chi EY: A role for cysteinyl leuko- trienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002;165:108-116.
4. Figueroa DJ, Breyer RM, Defoe SK, Kargman S, Daugherty BL, Waldburger K, Liu Q, Clements M, Zeng Z, O'Neill GP, Jones TR, Lynch KR, Austin CP, Evans JF: Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 2001; 163: 226-233.
5. Conti P, DiGioacchino M: MCP-1 and RAN- TES are mediators of acute and chronic inflammation. Allergy Asthma Proc 2001; 22: 133-137.
6. Lundien MC, Mohammed KA, Nasreen N, Tepper RS, Hardwick JA, Sanders KL, Van Horn RD, Antony VB: Induction of MCP-1 expression in airway epithelial cells: role of CCR2 receptor in airway epithelial injury. J Clin Immunol 2002;22:144-152.
7. 3H]5HT release. Immunology 1995;86:434-440.
8. Suzuki M, Hirai K, Kitani S, Takaishi T, Ki- hara H, Kasahara T, Ito K, Morita Y: Pharma- cologic study of basophil histamine release induced by monocyte chemotactic protein-1 with kinase inhibitors. Int Arch Allergy Immunol 1996; 111: 18-22.
9. Ichiyama T, Hasegawa M, Ueno Y, Maka- ta H, Matsubara T, Furukawa S: Cysteinyl leukotrienes induce monocyte chemoat- tractant protein 1 in human monocytes/ macrophages. Clin Exp Allergy 2005; 35: 1214-1219.
10. Garrington TP, Johnson GL: Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 1999; 11: 211-218.
11. Hommes DW, Peppelenbosch MP, van Den- venter SJH: Mitogen activate-protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 2003; 52: 144-151.
12. Minden A, Lin A, McMahon M, Lange-Car- ter C, Dérijard B, Davis RJ, Johnson GL, Kar- in M: Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MKK. Science 1994;266:1719-1723.
13. Faffe DS, Whitehead T, Moore PE, Baraldo S, Flynt L, Bourgeois K, Panettieri RA, Shore SA: IL-13 and IL-4 promote TARK release in human airway smooth muscle cells: role for IL-4 genotype. Am J Physiol Lung Cell Mol Physiol 2003; 285: 907-914.
14. Sekiya T, Tsunemi Y, Miyamasu M, Ohta K, Morita A, Saeki H, Matsushima K, Yoshie O, Tsuchiya N, Yamaguchi M, Yamamoto K, Tamaki K, Hirai K: Variations in the human TH2-specific chemokine TARK gene. Im- munogenetics 2003; 54:742-745.
15. Tsuchiya S, Yamabe M, Yamaguchi Y, Ko- bayashi Y, Konno T, Tada K: Establishment and characterization of human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980; 26: 171-176.
16. Hoshino M, Izumi T, Shimizu T: Leukotri- ene D4 activates mitogen-activated protein kinase through a protein kinase Cα-Raf-1- dependent pathway in human monocytic leukemia THP-1 cells. J Biol Chem 1998;273: 4878-4882.
17. Barnes PJ, Chung KF, Adcock IM: Cytokines as mediators of chronic asthma. Am J Respir Crit Care Med 1994;150(suppl):S42-S49.
18. Ménard G, Bissonnette EY: Priming of alveolar macrophages by leukotrine D4: potentia- tion of inflammation. Am J Respir Cell Mol Biol 2000; 23: 572-577.
19. Oosterhoff Y, Hoogsteden HC, Rutgers B, Kauffman HF, Postma DS: Lymphocyte and macrophage activation in bronchoalveolar lavage fluid in nocturnal asthma. Am J Respir Crit Care Med 1995;151:75-81.
20. Lane SJ, Sousa AR, Lee TH: The role of the macrophage in asthma. Allergy 1994; 49: 201-209.
21. Tonnel AB, Joseph M, Gosset P, Fournier E, Capron A: Stimulation of alveolar macro- phages in asthmatic patients after local provocation test. Lancet 1983;i:1406-1408.
22. Viksman MY, Bochner BS, Peebles RS, Schleimer RP, Liu MC: Expression of activation markers on alveolar macrophages in allergic asthmatics after endobronchial or whole-lung allergen challenge. Clin Immunol 2002; 104: 77-85.
23. Tang C, Rolland JM, Ward C, Thien F, Li X, Gollant S, Walters EH: Differential regulation of allergen-specific T(H2)- but not T(H1)-type responses by alveolar macro- phages in atopic asthma. J Allergy Clin Immunol 1998;102:368-375.
24. Peters SP: Leukotriene receptor antagonists in asthma therapy. J Allergy Clin Immunol 2003;111(suppl):S62-S70.
25. Rahman MS, Yamasaki A, Yang J, Shan L, Halayko AJ, Gounni AS: IL-17A induces eo- taxin-1/CC chemokine ligand 11 expression in human airway smooth muscle cells: role of MAPK (Erk1/2, JNK, and p38) pathways. J Immunol 2006;177:4064-4071.
26. Puig-Kröger A, Relloso M, Fernández-Ca- petillo O, Zubiaga A, Silva A, Bernabéu C, Corbí AL: Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells. Blood 2001;98:2175-2182.
27. Kallunki T, Deng T, Hibi M, Karin M: c-Jun can recruit JNK to phosphorylate dimeriza- tion partners via specific docking interactions. Cell 1996; 87: 929-939.
28. Chung KF, Barnes PJ: Cytokines in asthma. Thorax 1999; 54:825-857.
29. Fujisawa T, Ide K, Holtzman MJ, Suda T, Suzuki K, Kuroishi S, Chida K, Nakamura H: Involvement of the p38 MAPK pathway in IL-13-induced mucous cell metaplasia in mouse tracheal epithelial cells. Respirology 2008;13:191-202.
30. Pongratz G, McAlees JW, Conrad DH, Erbe RS, Haas KM, Sanders VM: The level of IgE produced by a B cell is regulated by norepi- nephrine in a p38 MAPK- and CD23-depen- dent manner. J Immunol 2006; 177:2926-2938.
31. Ip WK, Wong CK, Lam CW: Interleukin (IL)-4 and IL-13 up-regulate monocyte che- moattractant protein-1 expression in human bronchial epithelial cells: involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways. Clin Exp Immunol 2006;145:162-172.
32. Lucchi NW, Moore JM: LPS induces secretion of chemokines by human syncytiotro- phoblast cells in a MAPK-dependent manner. J Reprod Immunol 2007;73:20-27.
33. Hart LA, Krishnan VL, Adcock IM, Barnes PJ, Chung KF: Activation and localization of transcription factor, nuclear factor-KB, in asthma. Am J Respir Crit Care Med 1998; 158:1585-1592.
34. Jany B, Betz R, Schreck R: Activation of the transcription factor NF-κB in human tra- cheobronchial epithelial cells by inflammatory stimuli. Eur Respir J 1995; 8: 387-391.
35. Suzuki S, Takeuchi K, Ishinaga H, Basbaum C, Majima Y: Leukotriene D4 upregulates MUC2 gene transcription in human epithelial cells. Pharmacology 2008; 81: 221-228.
36. Kawano T, Matsuse H, Kondo Y, Machida I, Saeki S, Tomari S, Mitsuta K, Obase Y, Fuku- shima C, Shimoda T, Kohno S: Cysteinyl leu- kotrienes induce nuclear factor κB activation and RANTES production in a murine model of asthma. J Allergy Clin Immunol 2003;112:369-374.
37. Ichiyama T, Hasegawa S, Umeda M, Terai K, Matsubara T, Furukawa S: Pranlukast inhibits NF-κB activation in human monocyte and T cells. Clin Exp Allergy 2003; 33: 802-807.
38. Maeba S, Ichiyama T, Ueno Y, Makata H, Matsubara T, Furukawa S: Effect of montelu- kast on nuclear factor κB activation and proinflammatory molecules. Ann Allergy Asthma Immunol 2005; 94: 670-674.
39. Ichiyama T, Kajimoto M, Hasegawa M, Hashimoto K, Matsubara T, Furukawa S: Cyste- inyl leukotrienes enhance TNF-α-induced matrix metalloproteinase-9 in human mono- cytes/macrophages. Clin Exp Allergy 2007; 37: 608-614.